ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rybelsus 14 mg, Tabletten - 90
67446009 Novo Nordisk Pharma AG
Rybelsus 14 mg, Tabletten24.03.2020
  24.03.2020
Semaglutide (A10BJ06) 
WHO-DDD 
07.06.20.90
07.06.20. 
B  
Yes 
IP 
304.25Yes
    
10 %347.30
7680674460091Biotechnologika
  
Composition
semaglutidum 14 mg, natrii salcaprozas corresp. natrium 22.9 mg, cellulosum microcristallinum, povidonum K 90, magnesii stearas, pro compresso.
Packungsbestandteile
Tablets 
 
Active AgentDose
Semaglutidum14 mg
BAG: Active AgentDose
Semaglutidum14 mg
 
Inactive agentsDose
Cellulosum Microcristallinum 
Magnesii Stearas 
Natrii Salcaprozas 
Povidonum K90
Pro Compresso 
 
Source
Data was imported : 04.10.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home